NAD(P)H:quinone oxidoreductase 1 (NQO1):: chemoprotection, bioactivation, gene regulation and genetic polymorphisms

被引:526
作者
Ross, D
Kepa, JK
Winski, SL
Beall, HD
Anwar, A
Siegel, D
机构
[1] Univ Colorado, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Ctr Canc, Denver, CO 80262 USA
[3] Univ Montana, Sch Pharm, Dept Pharmaceut Sci, Missoula, MT 59812 USA
关键词
NQO1 (NAD(P)H : quinone oxidoreductase 1); quinone; vitamin E; ubiquinone; antitumor quinones; gene regulation; antioxidant response element (ARE) polymorphisms;
D O I
10.1016/S0009-2797(00)00199-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
NAD(P)H:quinone oxidoreductase 1 (NQO1) is an obligate two-electron reductase that is involved in chemoprotection and can also bioactivate certain antitumor quinones, This review focuses on detoxification reactions catalyzed by NQO1 and its role in antioxidant defense via the generation of antioxidant forms of ubiquinone and vitamin E, Bioactivation reactions catalyzed by NQO1 are also summarized and the development of new antitumor agents for the therapy of solid tumors with marked NQO1 content is reviewed. NQO1 gene regulation and the role of the antioxidant response element and the xenobiotic response element in transcriptional regulation is summarized. An overview of genetic polymorphisms in NQO1 is presented and biological significance for chemoprotection, cancer susceptibility and antitumor drug action is discussed. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:77 / 97
页数:21
相关论文
共 151 条
  • [1] REGULATION OF C-JUN EXPRESSION DURING HYPOXIC AND LOW-GLUCOSE STRESS
    AUSSERER, WA
    BOURRATFLOECK, B
    GREEN, CJ
    LADEROUTE, KR
    SUTHERLAND, RM
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (08) : 5032 - 5042
  • [2] BAYNEY RM, 1987, J BIOL CHEM, V262, P572
  • [3] Indolequinone antitumor agents: Relationship between quinone structure and rate of metabolism by recombinant human NQO1
    Beall, HD
    Hudnott, AR
    Winski, S
    Siegel, D
    Swann, E
    Ross, D
    Moody, CJ
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (05) : 545 - 548
  • [4] Mechanisms of action of quinone-containing alkylating agents I: NQO1-directed drug development
    Beall, HD
    Winski, SL
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2000, 5 : D639 - D648
  • [5] BEALL HD, 1994, CANCER RES, V54, P3196
  • [6] Indolequinone antitumor agents:: Correlation between quinone structure, rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase, and in vitro cytotoxicity
    Beall, HD
    Winski, S
    Swann, E
    Hudnott, AR
    Cotterill, AS
    O'Sullivan, N
    Green, SJ
    Bien, R
    Siegel, D
    Ross, D
    Moody, CJ
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (24) : 4755 - 4766
  • [7] BEALL HD, 1995, MOL PHARMACOL, V48, P499
  • [8] CONVERSION OF 4-NITROQUINOLINE 1-OXIDE (4NQO) TO 4-HYDROXYAMINOQUINOLINE 1-OXIDE BY A DICUMAROL-RESISTANT HEPATIC-4NQO NITROREDUCATASE IN RATS AND MICE
    BENSON, AM
    [J]. BIOCHEMICAL PHARMACOLOGY, 1993, 46 (07) : 1217 - 1221
  • [9] INCREASE OF NAD(P)H-QUINONE REDUCTASE BY DIETARY ANTIOXIDANTS - POSSIBLE ROLE IN PROTECTION AGAINST CARCINOGENESIS AND TOXICITY
    BENSON, AM
    HUNKELER, MJ
    TALALAY, P
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (09): : 5216 - 5220
  • [10] The role of DT-diaphorase in the maintenance of the reduced antioxidant form of coenzyme Q in membrane systems
    Beyer, RE
    SeguraAguilar, J
    DiBernardo, S
    Cavazzoni, M
    Fato, R
    Fiorentini, D
    Galli, MC
    Setti, M
    Landi, L
    Lenaz, G
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (06) : 2528 - 2532